Page last updated: 2024-11-05

trimethylolpropane trimethacrylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Trimethylolpropane trimethacrylate (TMPTMA) is a trifunctional monomer commonly used in dental composites, acrylic resins, and coatings. It is synthesized through the esterification of trimethylolpropane (TMP) with methacrylic acid. TMPTMA plays a crucial role in the polymerization process, forming a cross-linked network that provides strength and durability to the final product. Its properties, such as its high reactivity and ability to form strong bonds, make it an important component in various applications. TMPTMA is studied extensively to understand its impact on material properties, biocompatibility, and potential health effects. Research efforts focus on optimizing its use, minimizing potential risks, and exploring alternative monomers with improved characteristics.'

trimethylolpropane trimethacrylate: acrylate derivative found in ultraviolet curing inks; structure in 1st source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18689
CHEMBL ID1901244
CHEBI ID35029
SCHEMBL ID23636
MeSH IDM0091967

Synonyms (88)

Synonym
2-ethyl-2(hydroxymethyl)-1,3-propanediol trimethacrylate
wln: 1uy1&vo1x2&1ovy1&u1&1ovy1&u1
sr 350
3290-92-4
trimethylolpropane trimethacrylate
nsc-84261
ptma
trimethylolpropane trimethancrylate
methacrylic acid,3-propanediol
1, 2-ethyl-2-(hydroxymethyl)-, trimethacrylate
1,1-trimethylolpropane trimethacrylate
2-propenoic acid, 2-ethyl-2-[[(2-methyl-1-oxo-2-propenyl)oxy]methyl]-1,3-propanediyl ester
nsc84261
chemlink 30
saret 515
brn 5961805
1,3-propanediol, 2-ethyl-2-hydroxymethyl-, trimethacrylate
atm 11
hi-cross m
einecs 221-950-4
chemlink 3080
acryester tmp
td 1500 s
2-propenoic acid, 2-methyl-, 2-ethyl-2-(((2-methyl-1-oxo-2-propenyl)oxy)methyl)-1,3-propanediyl ester
sartomer sr 350
monocizer td 1500
sartomer 350
blemmer ptt
tmpt (crosslinking agent)
nk ester tmpt
propylidynetrimethyl trimethacrylate
methacrylic acid, 1,1,1-trihydroxymethyl propane triester
perkalink 400
1,1,1-trimethylolpropane trimethacrylate
nk ester m tmpt
perkalink 400-50d
methacrylic acid, triester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol
1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-, trimethacrylate
light ester tmp
ccris 530
td 1500
nsc 84261
ptma (van)
tmpt
trimethylolpropane trimethacrylate, contains 250 ppm monomethyl ether hydroquinone as inhibitor, technical grade
NCGC00164106-01
2-propenoic acid, 2-methyl-, 2-ethyl-2-[[(2-methyl-1-oxo-2-propenyl)oxy]methyl]-1,3-propanediyl ester
2,2-bis(methacryloyloxymethyl)butyl methacrylate
2,2-bis(2-methylprop-2-enoyloxymethyl)butyl 2-methylprop-2-enoate
2-ethyl-2-hydroxymethyl-1,3-propanediol trimethacrylate
T0912
NCGC00164106-02
ec 221-950-4
2-propenoic acid, 2-methyl-, 1,1'-(2-ethyl-2-(((2-methyl-1-oxo-2-propen-1-yl)oxy)methyl)-1,3-propanediyl) ester
s734uc120f ,
unii-s734uc120f
cas-3290-92-4
tox21_303195
dtxcid607530
NCGC00257184-01
dtxsid3027530 ,
NCGC00259343-01
tox21_201794
tmptma
FT-0612237
AKOS015915461
trimethylolpropane trimethacrylate [inci]
2-ethyl-1,3-dimethacryloxy-2-(methacryloxymethyl)propane
SCHEMBL23636
2-ethyl-2-((methacryloyloxy)methyl)propane-1,3-diyl bis(2-methylacrylate)
2,2-bis[(methacryloyloxy)methyl]butyl 2-methylacrylate #
2-methyl-2-propenoic acid 2-ethyl-2-[[(2-methyl-1-oxo-2-propenyl)oxy]methyl]-1,3-propanediyl ester
OKKRPWIIYQTPQF-UHFFFAOYSA-N
2,2-bis(methacryloxymethyl)butyl methacrylate
mfcd00008588
trimethylolpropane trimethacrylate (stabilized with mehq)
CHEBI:35029 ,
CHEMBL1901244
trimethylolpropane trimethacrylate, 80%, contains 175 ppm mehq as stabilizer
trimethylolpropane trimethacrylate (stabilised with mehq)
J-018931
2-ethyl-2-(methacryloyloxymethyl)propane-1,3-diyl bis(2-methylacrylate)
2-ethyl-2-((methacryloyloxy)methyl)propane-1,3-diylbis(2-methylacrylate)
Q27116373
trimethylolpropanetrimethacrylate
AS-76611
F87659
1,1,1-trimethylolpropane trimethacrylate 100 microg/ml in acetonitrile

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" It has been used extensively in orthopedics; however, adverse effects were associated with its use."( Development of new bone cement utilizing low toxicity monomers.
Kadoma, Y; Morita, S; Ono, S; Takakuda, K, 2008
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbonyl compoundAny compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (13)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
SMAD family member 2Homo sapiens (human)Potency19.60320.173734.304761.8120AID1346859; AID1346924
SMAD family member 3Homo sapiens (human)Potency19.60320.173734.304761.8120AID1346859; AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency17.95550.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency69.63720.000221.22318,912.5098AID1259243
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency2.51190.000214.376460.0339AID588533
retinoid X nuclear receptor alphaHomo sapiens (human)Potency24.93210.000817.505159.3239AID1159527
estrogen nuclear receptor alphaHomo sapiens (human)Potency46.90860.000229.305416,493.5996AID743069; AID743075; AID743080
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency60.53780.023723.228263.5986AID743222
thyroid stimulating hormone receptorHomo sapiens (human)Potency17.49210.001628.015177.1139AID1224843
activating transcription factor 6Homo sapiens (human)Potency2.51400.143427.612159.8106AID1159516
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency17.65060.057821.109761.2679AID1159526
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency1.00000.010039.53711,122.0200AID588547
heat shock protein beta-1Homo sapiens (human)Potency13.26030.042027.378961.6448AID743210; AID743228
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (62)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (8.06)18.7374
1990's8 (12.90)18.2507
2000's15 (24.19)29.6817
2010's32 (51.61)24.3611
2020's2 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.96 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index73.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.56%)5.53%
Reviews1 (1.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other62 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]